Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company ...

Tanya Siddiqi, MD, shares her personal experience using continuous BTK inhibitor therapy for the treatment of patients with ...

Six-year data show continuous zanubrutinib keeps CLL controlled longer than bendamustine-rituximab, including high-risk ...

PORTSMOUTH, Va. (WAVY) – In a video for the Virginia Chapter of Man Up To Cancer called “Gathering of Wolves”, you hear this: ...

At a tense cabinet meeting where several members lobbied on behalf of the shah, he asked: "What are you guys going to advise ...

Brooke Hogan has spoken out about rumors that she has a ‘thing’ with Scott McGillivray, her costar on HGTV’s home renovation ...

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has highlighted encouraging early clinical data and fresh funding in its March 2026 ...

Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased ...

A competing risk model provides well-calibrated absolute risk estimates for a first metachronous cutaneous squamous cell carcinoma (cSCC) after an index tumor, according to a study published online ...

Reports First-Quarter Diluted EPS of $0.39 on a GAAP Basis, a Decrease of 45.8 Percent; Adjusted Diluted EPS of $2.65, an Increase of 7.7 Percent; These Results Include ...

Mary Alice Glen was 37 years old when she was diagnosed with breast cancer in 1996. Years earlier, her mother died from ovarian cancer. One of her sisters had breast cancer. A brother h ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...